Adam Taich is an accomplished finance and strategy executive with extensive experience in the biotechnology and life sciences sectors. Currently serving as the Chief Financial Officer at 10x Genomics, Adam previously held the position of Chief Strategy Officer at Standard BioTools and served as both Chief Executive Officer and Chief Business Officer at SomaLogic. Adam's background also includes leadership roles at Thermo Fisher Scientific, where responsibilities encompassed Vice President and General Manager positions across Molecular Biology and Protein and Cell Analysis, as well as Vice President of Strategy and Business Development. Early in the career, Adam began in mergers and acquisitions as an Associate at Donaldson, Lufkin & Jenrette. Adam Taich earned a BA in Political Science and Russian from Miami University, following an education at Mary Institute and St. Louis Country Day School.
August, 2024 - present